Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ethnopharmacological Study of the Medicinal Plants Used in the Treatment of Sickle Cell Anemia in the West Region of Cameroon. | Evid Based Complement Alternat Med | 2022 | 35518347 | PubTator, text mining | PubMed |
| The Okur-Chung Neurodevelopmental Syndrome Mutation CK2K198R Leads to a Rewiring of Kinase Specificity. | Front Mol Biosci | 2022 | 35517865 | PubTator, text mining | PubMed |
| Restoration of Sarco/Endoplasmic Reticulum Ca2+-ATPase Activity Functions as a Pivotal Therapeutic Target of Anti-Glutamate-Induced Excitotoxicity to Attenuate Endoplasmic Reticulum Ca2+ Depletion. | Front Pharmacol | 2022 | 35517826 | PubTator, text mining | PubMed |
| Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases. | J Neurodev Disord | 2022 | 35501679 | PubTator, text mining | PubMed |
| The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population. | Evol Bioinform Online | 2022 | 35497687 | PubTator, text mining | PubMed |
| Up to What Extent Does Dravet Syndrome Benefit From Neurostimulation Techniques? | Front Neurol | 2022 | 35493838 | PubTator, text mining | PubMed |
| CDKL5 deficiency disorder: clinical features, diagnosis, and management. | Lancet Neurol | 2022 | 35483386 | PubTator, text mining | PubMed |
| Value of genetic testing for pediatric epilepsy: Driving earlier diagnosis of ceroid lipofuscinosis type 2 Batten disease. | Epilepsia | 2022 | 35474188 | PubTator, text mining | PubMed |
| Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants. | Genome Med | 2022 | 35468861 | PubTator, text mining | PubMed |
| A human coronavirus OC43-derived polypeptide causes neuropathic pain. | EMBO Rep | 2022 | 35466531 | PubTator, text mining | PubMed |
| Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discovery. | Hum Mutat | 2022 | 35460582 | PubTator, text mining | PubMed |
| Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases. | Int J Mol Sci | 2022 | 35457230 | PubTator, text mining | PubMed |
| Model-informed drug development of voxelotor in sickle cell disease: Exposure-response analysis to support dosing and confirm mechanism of action. | CPT Pharmacometrics Syst Pharmacol | 2022 | 35447017 | PubTator, text mining | PubMed |
| The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan. | Transfusion | 2022 | 35441384 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis. | Front Mol Neurosci | 2022 | 35431799 | PubTator, text mining | PubMed |
| Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapy. | J Extracell Vesicles | 2022 | 35430766 | PubTator, text mining | PubMed |
| Postnatal temporal changes of foetal haemoglobin in prematurely born infants. | Acta Paediatr | 2022 | 35429186 | PubTator, text mining | PubMed |
| 'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies. | Trends Pharmacol Sci | 2022 | 35427475 | PubTator, text mining | PubMed |
| Acute encephalopathy with biphasic seizures and restricted diffusion. | J Paediatr Child Health | 2022 | 35426454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers?page=42